FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

NuCare Pharmaceuticals Valsartan/HCTZ 160/25mg Tablets Recall

Valsartan/HCTZ 160/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceutic…

NuCare Pharmaceuticals Inc · Orange, CA

Risk level
Class II
Reported by FDA
Aug 15, 2018
Recall ID
D-1038-2018
Check your lot numberHow we source this data

Summary

NuCare Pharmaceuticals recalled Valsartan/HCTZ 160/25mg Tablets starting Jul 30, 2018. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1038-2018 on Aug 15, 2018. Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Status: Terminated.

Why it was recalled

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Product description

Valsartan/HCTZ 160/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867,

Lot numbers, UPCs & expiration codes

Lot # T11443; Exp. 02/28/2019

Where it was sold

Distributed to three customers in Fl and CA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1038-2018
Classification
Class II
Status
Terminated
Recall initiated
Jul 30, 2018
FDA report date
Aug 15, 2018
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
NuCare Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-1038-2018, exactly as published.

Show all FDA fields
City
Orange
State
CA
Status
Terminated
Country
United States
Event ID
80701
Address
622 W Katella Ave
Code information
Lot # T11443; Exp. 02/28/2019
Postal code
92867-4608
Report date
Aug 15, 2018
Product type
Drugs
Recall number
D-1038-2018
Classification
Class II
Recalling firm
NuCare Pharmaceuticals Inc
Termination date
Apr 22, 2021
Reason for recall
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Valsartan/HCTZ 160/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Pharmaceuticals, Inc., Orange, CA 92867,
Distribution pattern
Distributed to three customers in Fl and CA
Recall initiation date
Jul 30, 2018
Initial firm notification
Letter
Center classification date
Aug 3, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1038-2018, published Aug 15, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls